ClinicalTrials.gg
Drug

Domperidone clinical trials

Also written Motilium.

studies test it
34
open now
2
in phase 3
9
first study started
2003

How each study uses Domperidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Domperidone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Domperidone
22
domperidone maleate
3
Molax
2
Domperidone 10mg
2

Brand

Motilium
7

Development codes

KW 5338
1
R 33,812
1
JNJ-17296812
1

In one entry with another drug

Given together, or one or the other

Lansoprazole/Domperidone
2
Duolans
2

Studies by the year they started

34 studies that test it; most in 2013 (5)

Studies that test Domperidone, by start year
YearStudies
20031
20062
20071
20084
20091
20102
20124
20135
20141
20153
20161
20171
20182
20191
20201
20211
20221
20231
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2
Phase 2
8
Phase 3
9
Phase 4
6
No phase
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 27

Janssen Research & Development, LLC (2) · University of Calgary (2) · Neutec Ar-Ge San ve Tic A.Ş (2) · M.D. Anderson Cancer Center (1) · Xian-Janssen Pharmaceutical Ltd. (1) · Ain Shams University (1) · Mansoura University Children Hospital (1) · Children's Hospital of Fudan University (1)

Often tested with

Tested in the same studies.

Lansoprazole (2) · Omeprazole (1) · Alginic Acid (1) · Moxifloxacin (1) · Methylphenidate (1) · Levodopa (1) · Carbidopa (1) · Itopride (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test Domperidone, phase 3 first.

Studies

Open first, then newest update. How each study uses Domperidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 34

See all 34 studies that test Domperidone →

Given beside what is tested · 1 — Domperidone is usual care or a partner of the new treatment
As the comparator · 9 — what is tested is compared with Domperidone

Codes

What other systems call Domperidone · ClinicalTrials.gg INT007392

  • MeSH (NLM) D004294DomperidoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 5587267Z69DOMPERIDONEConfirmed FDA, NLM, Wikidata
  • RxNorm 3626Confirmed FDA, Wikidata
  • Wikidata Q424238domperidoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C454DomperidoneOne source FDA
  • DrugBank DB01184One source Wikidata

Also registered as domperidone maleate (UNII 899U5WF46A · RxNorm 236099).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.